The Global Scalp Microneedling Market, by Product type (Dermaroller, Dermapen, and Derma-stamp), by Size (Under 0.25 mm, 0.25mm-0.3mm, 0.75mm-1.0mm, 1.0mm-1.5mm, and Above 1.5mm), by Needle Material (Silicon Microneedle, Metal Microneedle, and Glass Microneedle), by End User (Hospitals, Dermatology Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) is estimated to be valued at US$ 179.5 Million in 2022 and projected to exhibit a CAGR of 8.2% during the forecast period (2022-2030).
Increasing clinical studies are being conducted to evaluate the use of scalp microneedling (MN) devices for hair loss disorders, which is projected to provide a profitable opportunity for industry participants to introduce their novel products. For instance, according to a review article published in December 2021 by Springer Nature Switzerland AG, a part of Springer Nature, A literature search was conducted through PubMed up to November 2021 to identify original articles evaluating the use of MN on hair loss disorders. A total of 22 clinical studies featuring 1127 subjects were included. It was observed that MN improved hair parameters when paired with 5% minoxidil, growth factor solutions, and/or platelet-rich plasma (PRP) topicals, or when introduced to subjects whose hair count changes had plateaued for ≥ 6 months on other treatments.
Global Scalp Microneedling Market – Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic has affected various industries globally. Key players operating in the global scalp microneedling market are facing major challenges on various fronts due to the COVID-19 pandemic. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported globally, as of May 18, 2022, are approximately 520,372,492 confirmed cases with 6,270,232 deaths.
The COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to lockdowns, several countries such as Saudi Arabia, U.A.E, Egypt, and others are also facing problems with regard to the transportation of several drugs from one place to another.